Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Astrazeneca (AZN) Share News

AstraZeneca gets US approval for Koselugo for rare genetic disorder

20th Nov 2025 09:06

(Alliance News) - AstraZeneca PLC on Thursday said US regulators have approved its drug Koselugo for use in adults with neurofibromatosis type 1, expanding access to a treatment already used in children with the rare genetic condition. Read More

LONDON MARKET OPEN: Stocks sold off on lingering tech worry

18th Nov 2025 08:45

(Alliance News) - Stock prices in Europe opened in the red on Tuesday, following sharp falls in Asia and as equities in New York struggled overnight, with the S&P 500 ending below a key level for the first time a number of months. Read More

LONDON MARKET CLOSE: Stocks hit, bond yields jump amid tax U-turn talk

14th Nov 2025 17:03

(Alliance News) - Stocks fell and bonds yields spiked in volatile trading on Friday amid uncertainty over UK budget proposals after an apparent u-turn on tax policy by Chancellor Rachel Reeves. Read More

DIRECTOR DEALINGS: Springfield Properties chair banks GBP2.6 million

14th Nov 2025 11:21

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: RBC and Deutsche like SSE; Barclays likes Wizz

14th Nov 2025 10:00

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BROKER RATINGS: Jefferies cuts Croda; Deutsche cuts Ashmore

11th Nov 2025 09:50

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

AstraZeneca says Baxdrostat reduces 24-hour systolic blood pressure

10th Nov 2025 04:32

(Alliance News) - AstraZeneca PLC on Sunday announced results from the phase 3 trial of its Baxdrostat treatment which showed a statistically significant reduction in the systolic blood pressure of patients with resistant hypertension. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Weir; UBS ups British Land

7th Nov 2025 10:14

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET CLOSE: FTSE 100 slips amid BoE rate hold, fresh US falls

6th Nov 2025 16:59

(Alliance News) - The FTSE 100 fell on Thursday as the Bank of England left interest rates unchanged in a tight vote and investors weighed a deluge of earnings from leading blue-chip names. Read More

LONDON MARKET OPEN: Stocks steady before BoE amid barrage of earnings

6th Nov 2025 09:09

(Alliance News) - Stock prices in London opened steady on Thursday amid a delude of earnings, as investors focus on a finely balanced interest rate decision from the Bank of England. Read More

AstraZeneca backs guidance as third quarter sales beat expectations

6th Nov 2025 08:28

(Alliance News) - AstraZeneca PLC on Thursday said a strong performance in 2025 so far, with third quarter sales ahead of forecast, leaves it well-placed to sustain growth through 2026. Read More

LONDON BRIEFING: AstraZeneca earnings rise; J Sainsbury ups guidance

6th Nov 2025 07:51

(Alliance News) - AstraZeneca reports higher earnings, J Sainsbury raises its profit guidance and interim dividend while ITV warns of a tough advertising market. Read More

Hutchmed completes Saffron trial enrolment, results due 2026

5th Nov 2025 11:48

(Alliance News) - Hutchmed China Ltd on Wednesday said patient enrolment has been completed for its phase 3 Saffron trial evaluating the combination of Orpathys and Tagrisso in certain lung cancer patients, with topline results expected in the first half of 2026. Read More

LONDON MARKET CLOSE: Stocks mixed and pound dips amid budget tax hints

4th Nov 2025 16:59

(Alliance News) - The FTSE 100 outperformed European and US peers on Tuesday, but sterling fell further, as Chancellor Rachel Reeves laid the groundwork for further tax rises in this month’s budget. Read More

AstraZeneca hails phase 3 gefurulimab results in myasthenia gravis

31st Oct 2025 10:08

(Alliance News) - AstraZeneca PLC on Thursday said phase 3 data regarding its investigational inhibitor gefurulimab met its primary endpoint in myasthenia gravis activities of daily living. Read More

Daiichi Sankyo, AstraZeneca launch phase three Enhertu lung trial

31st Oct 2025 02:46

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they began new phase 3 clinical trial testing of an intravenous treatment for advanced lung cancer. Read More

UK earnings, trading statements calendar - next 7 days

30th Oct 2025 16:16

AstraZeneca hails EU approval of Koselugo for form of neurofibromas

28th Oct 2025 09:36

(Alliance News) - AstraZeneca PLC on Tuesday said Alexion's selective inhibitor Koseluga has been approved in the EU for the treatment of symptomatic, inoperable plexiform neurofibromas, PN, in adult patients with neurofibromatosis type 1, NF 1. Read More

UK shareholder meetings calendar - next 7 days

27th Oct 2025 14:26

LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'

27th Oct 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

FTSE 100 Latest

Value9,527.65

Change20.24